期刊文献+

曲美他嗪治疗不稳定型心绞痛疗效评价 被引量:2

下载PDF
导出
摘要 目的评价在常规治疗基础上加用曲美他嗪治疗不稳定型心绞痛的疗效。方法64例确诊为不稳定型心绞痛的患者被随机分为常规治疗组(32例)和曲美他嗪治疗组(32例),治疗90d。观察患者的心率、血压、心电图、每周心绞痛发作次数、舌下含服硝酸甘油用量及症状改善情况及副作用。结果与常规治疗组比较,曲美他嗪治疗组心绞痛发作及每周硝酸甘油用量显著减少,心肌缺血减轻,无明显的血流动力学效应和药物相关不良事件发生。结论在常规治疗基础上加用曲美他嗪治疗不稳定型心绞痛有良好效果而无明显的血流动力学效应和不良反应。
出处 《中国血液流变学杂志》 CAS 2009年第4期549-550,共2页 Chinese Journal of Hemorheology
  • 相关文献

参考文献7

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2153
  • 2Kantor PF, Lucien A,Kozak R,et al.The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase[J]. Circ Res,2000,86:580-588.
  • 3Meng D,Feng L,Chen XJ.et al.Trimetazidine improved Ca2+ handling in isoprenaline-mediated myocardial injury of rats [J].Exp Physiol,2006,91 (3):591-601.
  • 4Di Napoli P,Taccardi AA, Barsotti A.Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy[J].Heart,2005,91 (2): 161 - 165.
  • 5Di Napoli P.Taccardi AA,Di Giovanni P.et al.Abstract 1598: Trimetazidine Reduces Mortality And Hospitalization In Patients With Ischemic Cardiomyopathy:A 4-year Follow- up Post-hoc Analysis[J].Circulation,2007,116:II_333-II_334.
  • 6Szwed H, Sadowski Z,Elikowski W,et al.Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized,double-blind,multicentre study (TRIMPOL Ⅱ )[J].Eur Heart J,2001,22(24):2267-2274.
  • 7Bonello L,Sbragia P,Amabile N,et al.Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention[J].Heart,2007, 93(6):703-707.

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2152

同被引文献44

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部